207 related articles for article (PubMed ID: 24034269)
1. Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours.
DeInnocentes P; Perry AL; Graff EC; Lutful Kabir FM; Curtis Bird R
Vet Comp Oncol; 2015 Sep; 13(3):322-36. PubMed ID: 24034269
[TBL] [Abstract][Full Text] [Related]
2. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
3. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
Mayr B; Dressler A; Reifinger M; Feil C
Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
6. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
7. [Expression of 39 HOX genes in esophageal cancer cell lines].
Gu ZD; Chen XM; Zhang W; Gu J; Chen KN
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):365-7. PubMed ID: 17659465
[TBL] [Abstract][Full Text] [Related]
8. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
9. Hox genes in normal and neoplastic mouse mammary gland.
Friedmann Y; Daniel CA; Strickland P; Daniel CW
Cancer Res; 1994 Nov; 54(22):5981-5. PubMed ID: 7954431
[TBL] [Abstract][Full Text] [Related]
10. Prognostic status of p53 gene mutation in canine mammary carcinoma.
Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.
Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M
Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989
[TBL] [Abstract][Full Text] [Related]
12. Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.
Lutful Kabir FM; DeInnocentes P; Bird AC; Bird RC
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):519-530. PubMed ID: 34014456
[TBL] [Abstract][Full Text] [Related]
13. Trisomy 1 in a canine mammary tubular adenocarcinoma, complex type.
Mayr B; Eschborn U; Loupal G; Schleger W
Vet Pathol; 1993 May; 30(3):311-3. PubMed ID: 8333114
[No Abstract] [Full Text] [Related]
14. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
16. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
[TBL] [Abstract][Full Text] [Related]
17. Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms.
Mayr B; Reifinger M; Alton K
Vet Res Commun; 1999 Aug; 23(5):285-91. PubMed ID: 10493115
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
19. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of HOX genes in human invasive breast carcinoma.
Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
